Rhythm Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Rhythm Pharmaceuticals using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $-0.82 | $-0.72 | -13.9 % |
| Q2 | 2025-08-05 | $-0.75 | $-0.67 | -11.9 % |
| Q1 | 2025-05-07 | $-0.81 | $-0.68 | -19.1 % |
| Q4 | 2025-02-26 | $-0.72 | $-0.73 | 1.37 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $51.30M | $50.48M | 1.61 % |
| Q2 | 2025-08-05 | $48.50M | $43.55M | 11.4 % |
| Q1 | 2025-05-07 | $32.70M | $40.70M | -19.7 % |
| Q4 | 2025-02-26 | $41.83M | $38.48M | 8.71 % |
Rhythm Pharmaceuticals (RYTM) is scheduled to report earnings on February 25, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
The Actual EPS was $-0.82, which missed the estimate of $-0.72.
The Actual Revenue was $51.3M, which beat the estimate of $50.5M.
Browse earnings estimates, EPS, and revenue on all stocks.